Medical elastomer market projected to reach $19.2 billion by 2032

Pune, India – The global medical elastomer market is set to reach $19.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.7% from 2024, according to a report by Acumen Research and Consulting. This growth is driven by advanced material innovations, rising demand for disposable medical devices, and expanding healthcare infrastructure worldwide.

Medical elastomers—valued for their biocompatibility, flexibility, and chemical resistance—are widely used in products such as tubing, catheters, implants, syringes, and seals. The increasing prevalence of chronic diseases and the shift toward minimally invasive procedures are fueling demand across hospitals and diagnostic centers.

Thermoplastic elastomers (TPEs) are expected to dominate the market, accounting for 68% of the share in 2023, while medical tubes are projected to see 29% growth in the same year. North America remains a key market, valued at $3.28 billion in 2023, while the Asia-Pacific region is forecast to grow at a CAGR of over 10.5%, driven by industrialization and healthcare investment.

Leading companies in the sector include Dow Inc., Wacker Chemie AG, Momentive Performance Materials, Saint-Gobain Performance Plastics, and Zeon Corporation, all of which are investing in material innovation, sustainability, and digital manufacturing technologies to enhance product performance and safety.
With strong momentum across regions and applications, the medical elastomer market is poised for robust expansion over the next decade.